The Prolyl Peptidases PRCP/PREP Regulate IRS-1 Stability Critical for Rapamycin-induced Feedback Activation of PI3K and AKT
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Prolyl Peptidases PRCP/PREP Regulate IRS-1 Stability Critical for Rapamycin-induced Feedback Activation of PI3K and AKT
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 289, Issue 31, Pages 21694-21705
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2014-06-17
DOI
10.1074/jbc.m114.550038
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prolylcarboxypeptidase promotes angiogenesis and vascular repair
- (2013) G. N. Adams et al. BLOOD
- Selective Requirement of PI3K/PDK1 Signaling for Kras Oncogene-Driven Pancreatic Cell Plasticity and Cancer
- (2013) Stefan Eser et al. CANCER CELL
- Insulin-Like Growth Factor Signaling as a Therapeutic Target in Pancreatic Cancer
- (2012) Simon Rieder et al. Anti-Cancer Agents in Medicinal Chemistry
- Targeting Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer – from Molecular Signalling to Clinical Trials
- (2012) Marco Falasca et al. Anti-Cancer Agents in Medicinal Chemistry
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Development of targeted therapies for pancreatic cancer
- (2011) Philip A Philip LANCET ONCOLOGY
- Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling
- (2011) Y. Yu et al. SCIENCE
- The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling
- (2011) P. P. Hsu et al. SCIENCE
- Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies
- (2010) Milind M Javle et al. BMC CANCER
- Insulin Receptor Substrate Regulation of Phosphoinositide 3-Kinase
- (2010) H. E. Metz et al. CLINICAL CANCER RESEARCH
- Crosstalk between Insulin/Insulin-like Growth Factor-1 Receptors and G Protein-Coupled Receptor Signaling Systems: A Novel Target for the Antidiabetic Drug Metformin in Pancreatic Cancer
- (2010) E. Rozengurt et al. CLINICAL CANCER RESEARCH
- Prolylcarboxypeptidase Regulates Proliferation, Autophagy, and Resistance to 4-Hydroxytamoxifen-induced Cytotoxicity in Estrogen Receptor-positive Breast Cancer Cells
- (2010) Lei Duan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The PI3K Pathway As Drug Target in Human Cancer
- (2010) Kevin D. Courtney et al. JOURNAL OF CLINICAL ONCOLOGY
- Advanced or Metastatic Pancreatic Cancer: Molecular Targeted Therapies
- (2010) Soley Bayraktar et al. MOUNT SINAI JOURNAL OF MEDICINE
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- Pancreatic cancer: molecular pathogenesis and new therapeutic targets
- (2009) Han H. Wong et al. Nature Reviews Gastroenterology & Hepatology
- Molecular targeted therapies for pancreatic cancer
- (2008) Daniel Borja-Cacho et al. AMERICAN JOURNAL OF SURGERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started